Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia (NEuroSIS)

This study has been completed.
Sponsor:
Collaborator:
European Union
Information provided by (Responsible Party):
Prof. Dr. med. Dirk Bassler, Msc, University Children's Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01035190
First received: December 17, 2009
Last updated: July 4, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2016
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):